Financhill
Sell
45

LUV Quote, Financials, Valuation and Earnings

Last price:
$33.4500
Seasonality move :
12.1%
Day range:
$32.5300 - $33.4386
52-week range:
$23.5800 - $36.1200
Dividend yield:
2.16%
P/E ratio:
204.00x
P/S ratio:
0.75x
P/B ratio:
1.92x
Volume:
14.9M
Avg. volume:
7M
1-year change:
14.48%
Market cap:
$20B
Revenue:
$26.1B
EPS (TTM):
-$0.07
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $22.4B $9B $15.8B $23.8B $26.1B
Revenue Growth (YoY) 2.11% -59.66% 74.51% 50.82% 9.56%
 
Cost of Revenues $16.4B $10.9B $11.7B $19.1B $21.9B
Gross Profit $6B -$1.9B $4.1B $4.8B $4.2B
Gross Profit Margin 26.68% -20.89% 26.06% 19.96% 16.19%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$8M -$158M $22M -$205M $62M
Operating Expenses $3B $1.9B $2.4B $3.7B $4B
Operating Income $3B -$3.8B $1.7B $1B $224M
 
Net Interest Expenses -- $282M $418M $84M --
EBT. Incl. Unusual Items $3B -$4.3B $1.3B $728M $633M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $657M -$1.2B $348M $189M $168M
Net Income to Company $2.3B -$3.1B $977M $539M $465M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.3B -$3.1B $977M $539M $465M
 
Basic EPS (Cont. Ops) $4.28 -$5.44 $1.65 $0.91 $0.78
Diluted EPS (Cont. Ops) $4.27 -$5.44 $1.61 $0.87 $0.76
Weighted Average Basic Share $538M $538M $592M $593M $595M
Weighted Average Diluted Share $539M $539M $609M $642M $640M
 
EBITDA $4.3B -$2.7B $3B $2.4B $2.4B
EBIT $3B -$3.9B $1.8B $1B $869M
 
Revenue (Reported) $22.4B $9B $15.8B $23.8B $26.1B
Operating Income (Reported) $3B -$3.8B $1.7B $1B $224M
Operating Income (Adjusted) $3B -$3.9B $1.8B $1B $869M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.8B $4.7B $6.2B $6.5B $6.9B
Revenue Growth (YoY) -68.2% 160.96% 32.93% 4.9% 5.29%
 
Cost of Revenues $2.7B $3.3B $5B $5.5B $5.8B
Gross Profit -$923M $1.4B $1.2B $1.1B $1.1B
Gross Profit Margin -51.48% 29.81% 19.52% 16.48% 16.26%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$35M -$29M -$37M $23M -$16M
Operating Expenses $488M $662M $819M $958M $1.1B
Operating Income -$1.4B $733M $395M $117M $38M
 
Net Interest Expenses $96M $104M $5M -- --
EBT. Incl. Unusual Items -$1.5B $600M $353M $237M $89M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$385M $154M $76M $44M $22M
Net Income to Company -$1.2B $446M $277M $193M $67M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.2B $446M $277M $193M $67M
 
Basic EPS (Cont. Ops) -$1.96 $0.75 $0.47 $0.32 $0.11
Diluted EPS (Cont. Ops) -$1.96 $0.73 $0.44 $0.31 $0.11
Weighted Average Basic Share $590M $592M $593M $596M $599M
Weighted Average Diluted Share $590M $607M $639M $640M $601M
 
EBITDA -$1.1B $1B $763M $671M $581M
EBIT -$1.4B $706M $428M $296M $143M
 
Revenue (Reported) $1.8B $4.7B $6.2B $6.5B $6.9B
Operating Income (Reported) -$1.4B $733M $395M $117M $38M
Operating Income (Adjusted) -$1.4B $706M $428M $296M $143M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $12.8B $12.8B $22.7B $25.4B $27.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.6B $10.2B $18.1B $20.9B $23.4B
Gross Profit $189M $2.6B $4.6B $4.5B $4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$95M -$30M -$259M $88M $19M
Operating Expenses $2.2B $2.2B $3B $4.3B $4.3B
Operating Income -$2B $358M $1.6B $243M -$361M
 
Net Interest Expenses $181M $411M $248M -- --
EBT. Incl. Unusual Items -$2.3B -$83M $1.1B $633M -$17M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$606M -$85M $263M $136M $32M
Net Income to Company -$1.7B $1M $827M $497M -$48M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1.7B $2M $827M $497M -$49M
 
Basic EPS (Cont. Ops) -$2.79 -- $1.40 $0.83 -$0.04
Diluted EPS (Cont. Ops) -$2.79 -$0.05 $1.28 $0.75 -$0.07
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$776M $1.6B $2.8B $2.3B $1.9B
EBIT -$2B $336M $1.4B $872M $208M
 
Revenue (Reported) $12.8B $12.8B $22.7B $25.4B $27.4B
Operating Income (Reported) -$2B $358M $1.6B $243M -$361M
Operating Income (Adjusted) -$2B $336M $1.4B $872M $208M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7B $10.7B $17.6B $19.3B $20.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.3B $7.5B $13.9B $15.8B $17.3B
Gross Profit -$1.2B $3.2B $3.7B $3.5B $3.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$95M $33M -$249M $44M $1M
Operating Expenses $1.4B $1.7B $2.3B $2.9B $3.2B
Operating Income -$2.6B $1.5B $1.4B $628M $43M
 
Net Interest Expenses $182M $311M $140M -- --
EBT. Incl. Unusual Items -$2.9B $1.2B $1B $918M $269M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$759M $338M $254M $201M $66M
Net Income to Company -$2.2B $909M $759M $717M $204M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.2B $910M $759M $717M $203M
 
Basic EPS (Cont. Ops) -$3.77 $1.54 $1.29 $1.20 $0.33
Diluted EPS (Cont. Ops) -$3.77 $1.49 $1.17 $1.12 $0.30
Weighted Average Basic Share $1.7B $1.8B $1.8B $1.8B $1.8B
Weighted Average Diluted Share $1.7B $1.8B $1.9B $1.9B $1.8B
 
EBITDA -$1.8B $2.5B $2.2B $2.2B $1.7B
EBIT -$2.7B $1.6B $1.3B $1.1B $436M
 
Revenue (Reported) $7B $10.7B $17.6B $19.3B $20.6B
Operating Income (Reported) -$2.6B $1.5B $1.4B $628M $43M
Operating Income (Adjusted) -$2.7B $1.6B $1.3B $1.1B $436M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.5B $11.1B $12.5B $9.5B $9.3B
Short Term Investments $1.5B $2.3B $3B $2.8B $2.2B
Accounts Receivable, Net $53M $46M $58M $117M $104M
Inventory $529M $414M $537M $790M $807M
Prepaid Expenses -- -- -- -- --
Other Current Assets $249M $285M $309M $440M $449M
Total Current Assets $6B $15.2B $18B $14.8B $14B
 
Property Plant And Equipment $18.4B $17.7B $16.4B $18.7B $20.6B
Long-Term Investments -- -- -- $235M $280M
Goodwill $970M $970M $970M $970M $970M
Other Intangibles $296M $295M $295M $296M $296M
Other Long-Term Assets $232M $337M $395M $31M $28M
Total Assets $25.9B $34.6B $36.3B $35.4B $36.5B
 
Accounts Payable $304M $111M $156M $277M $265M
Accrued Expenses $250M $306M $231M $491M $772M
Current Portion Of Long-Term Debt $734M $137M $371M -- --
Current Portion Of Capital Lease Obligations $438M $389M $321M $267M $237M
Other Current Liabilities $5M -- -- -- --
Total Current Liabilities $9B $7.5B $9.2B $10.4B $12.3B
 
Long-Term Debt $1.3B $9.7B $9.9B $7.9B $7.9B
Capital Leases -- -- -- -- --
Total Liabilities $16.1B $25.7B $25.9B $24.7B $26B
 
Common Stock $808M $888M $888M $888M $888M
Other Common Equity Adj -$81M -$62M $322M $174M -$149M
Common Equity $9.8B $8.9B $10.4B $10.7B $10.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $9.8B $8.9B $10.4B $10.7B $10.5B
 
Total Liabilities and Equity $25.9B $34.6B $36.3B $35.4B $36.5B
Cash and Short Terms $4.1B $13.3B $15.5B $12.3B $11.5B
Total Debt $2B $9.8B $10.3B $7.9B $7.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $12.1B $13B $10.4B $9.5B $8.5B
Short Term Investments $2.5B $3B $3.2B $2.2B $879M
Accounts Receivable, Net $48M $67M $85M $142M $50M
Inventory $426M $511M $776M $799M $770M
Prepaid Expenses -- -- -- -- --
Other Current Assets $248M $291M $381M $438M $601M
Total Current Assets $16.1B $18.6B $16.4B $14.6B $11.9B
 
Property Plant And Equipment $17.8B $16.7B $17.8B $20.4B $20.9B
Long-Term Investments -- -- -- $249M $354M
Goodwill $970M $970M $970M $970M $970M
Other Intangibles -- $295M $295M $296M $300M
Other Long-Term Assets $307M $373M $333M $255M $56M
Total Assets $35.6B $37.1B $35.9B $37B $34.8B
 
Accounts Payable $169M $234M $279M $329M $389M
Accrued Expenses $437M $414M $348M $586M $489M
Current Portion Of Long-Term Debt $720M $225M $381M $30M $2.9B
Current Portion Of Capital Lease Obligations $316M $243M $233M $220M $202M
Other Current Liabilities $28M -- -- -- --
Total Current Liabilities $7.8B $9.1B $10.4B $12.1B $13.5B
 
Long-Term Debt $10.1B $11B $8.3B $8B $5.1B
Capital Leases -- -- -- -- --
Total Liabilities $25.8B $26.9B $25B $25.9B $24.4B
 
Common Stock $888M $888M $888M $888M $888M
Other Common Equity Adj -$102M $310M $239M $31M -$37M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $9.8B $10.3B $10.9B $11.1B $10.4B
 
Total Liabilities and Equity $35.6B $37.1B $35.9B $37B $34.8B
Cash and Short Terms $14.6B $16B $13.7B $11.7B $9.4B
Total Debt $10.9B $11.2B $8.7B $8B $8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $2.3B -$3.1B $977M $539M $465M
Depreciation & Amoritzation $1.2B $1.3B $1.3B $1.4B $1.5B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$94M -$294M -$701M $422M -$89M
Change in Inventories -- -- -- -- --
Cash From Operations $4B -$1.1B $2.3B $3.8B $3.2B
 
Capital Expenditures $1B $515M $511M $3.9B $3.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$303M -$16M -$1.3B -$3.7B -$2.9B
 
Dividends Paid (Ex Special Dividend) -$372M -$188M -- -- -$428M
Special Dividend Paid
Long-Term Debt Issued -- $13.6B $1.1B -- --
Long-Term Debt Repaid -$615M -$5.5B -$905M -$3.1B -$85M
Repurchase of Common Stock -$2B -$451M -- -- --
Other Financing Activities -$43M -$144M $77M $8M $29M
Cash From Financing -$3B $9.7B $359M -$3B -$436M
 
Beginning Cash (CF) $1.9B $2.5B $11.1B $12.5B $9.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $694M $8.5B $1.4B -$3B -$204M
Ending Cash (CF) $2.5B $11.1B $12.5B $9.5B $9.3B
 
Levered Free Cash Flow $3B -$1.6B $1.8B -$156M -$389M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.2B $446M $277M $193M $67M
Depreciation & Amoritzation $316M $322M $335M $376M $438M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$124M -$22M $57M -$217M $194M
Change in Inventories -- -- -- -- --
Cash From Operations -$1.1B -$575M $234M $616M $114M
 
Capital Expenditures $89M $138M $1.1B $850M $527M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$434M -$411M -$1.1B -$64M $457M
 
Dividends Paid (Ex Special Dividend) -- -- -- -$214M -$216M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.3B -- -- -- --
Long-Term Debt Repaid -$58M -$189M -$1.9B -$11M -$11M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $33M $18M -- -$2M $1M
Cash From Financing $1.2B -$158M -$1.9B -$213M -$210M
 
Beginning Cash (CF) $12.4B $14.1B $13.2B $9.2B $8.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$242M -$1.1B -$2.8B $339M $361M
Ending Cash (CF) $12.1B $13B $10.4B $9.5B $8.5B
 
Levered Free Cash Flow -$1.1B -$713M -$845M -$234M -$413M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.7B $1M $827M $497M -$48M
Depreciation & Amoritzation $1.3B $1.3B $1.3B $1.5B $1.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $138M -$1.1B $280M -$145M $236M
Change in Inventories -- -- -- -- --
Cash From Operations $293M $1.5B $3.5B $3.3B $411M
 
Capital Expenditures $686M $418M $2.8B $4.2B $2.3B
Cash Acquisitions -- -- -- -- --
Cash From Investing $37M -$990M -$3B -$3.2B -$998M
 
Dividends Paid (Ex Special Dividend) -$188M -- -- -$428M -$431M
Special Dividend Paid
Long-Term Debt Issued $13.6B $1.1B -- -- --
Long-Term Debt Repaid -$5.3B -$842M -$3.1B -$690M -$34M
Repurchase of Common Stock -$1B -- -- -- --
Other Financing Activities -$134M $37M $37M $6M $6M
Cash From Financing $9.3B $382M -$3B -$1.1B -$407M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9.6B $871M -$2.5B -$946M -$994M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$393M $1.1B $693M -$881M -$1.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$2.2B $909M $759M $717M $204M
Depreciation & Amoritzation $940M $949M $984M $1.1B $1.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$60M -$819M $162M -$405M -$80M
Change in Inventories -- -- -- -- --
Cash From Operations -$531M $2.1B $3.2B $2.7B -$14M
 
Capital Expenditures $425M $328M $2.6B $2.8B $1.6B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$107M -$1.1B -$2.8B -$2.3B -$334M
 
Dividends Paid (Ex Special Dividend) -$188M -- -- -$428M -$431M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $13.6B $1.1B -- -- --
Long-Term Debt Repaid -$5B -$298M -$2.5B -$78M -$27M
Repurchase of Common Stock -$451M -- -- -- --
Other Financing Activities -$135M $46M $6M $4M -$19M
Cash From Financing $10.2B $923M -$2.4B -$466M -$437M
 
Beginning Cash (CF) $18.8B $37.2B $38.8B $27B $25.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $9.6B $1.9B -$2B $5M -$785M
Ending Cash (CF) $28.4B $39.1B $36.8B $27B $25B
 
Levered Free Cash Flow -$956M $1.7B $629M -$96M -$1.6B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.14% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock